Literature DB >> 28283899

Liposomal Co-Encapsulation of Two Novel Europium Complexes and Doxorubicin: Fluorescence Study.

Valeriya M Trusova1,2, Todor Deligeorgiev3, Galyna Gorbenko4.   

Abstract

The present study was undertaken to design the novel liposomal drug formulation containing doxorubicin and europium coordination complexes. It was shown that co-encapsulation of the drugs facilitates the partitioning and permeation of lanthanides into the lipid bilayer. The obtained results suggest that new drug platform may have potential application in the design of novel antitumor agents.

Entities:  

Keywords:  Doxorubicin; Drug combination; Lanthanides; Liposomal drug formulation

Mesh：

Substances：

Year:  2017        PMID： 28283899     DOI： 10.1007/s10895-017-2070-x

Source DB:  PubMed          Journal:  J Fluoresc        ISSN： 1053-0509            Impact factor:   2.217


  18 in total

1.  Core/shell nanofibers with embedded liposomes as a drug delivery system.

Authors:  Andrea Mickova; Matej Buzgo; Oldrich Benada; Michala Rampichova; Zdenek Fisar; Eva Filova; Martina Tesarova; David Lukas; Evzen Amler
Journal:  Biomacromolecules       Date:  2012-03-26       Impact factor: 6.988

2.  Pegylated liposome-encapsulated doxorubicin and cisplatin enhance the effect of radiotherapy in a tumor xenograft model.

Authors:  K J Harrington; G Rowlinson-Busza; K N Syrigos; R G Vile; P S Uster; A M Peters; J S Stewart
Journal:  Clin Cancer Res       Date:  2000-12       Impact factor: 12.531

Review 3.  Liposomal drug delivery systems: from concept to clinical applications.

Authors:  Theresa M Allen; Pieter R Cullis
Journal:  Adv Drug Deliv Rev       Date:  2012-10-01       Impact factor: 15.470

4.  The anionic phospholipid-mediated membrane interaction of the anti-cancer drug doxorubicin is enhanced by phosphatidylethanolamine compared to other zwitterionic phospholipids.

Authors:  G Speelmans; B de Kruijff
Journal:  Biochemistry       Date:  1997-07-15       Impact factor: 3.162

Review 5.  Developments in liposomal drug delivery systems.

Authors:  N Maurer; D B Fenske; P R Cullis
Journal:  Expert Opin Biol Ther       Date:  2001-11       Impact factor: 4.388

6.  Development of stealth liposome coencapsulating doxorubicin and fluoxetine.

Authors:  Jasmine Chiat-Ling Ong; Feng Sun; Eli Chan
Journal:  J Liposome Res       Date:  2011-01-12       Impact factor: 3.648

7.  Interaction of C60 fullerene complexed to doxorubicin with model bilipid membranes and its uptake by HeLa cells.

Authors:  Yu Prylutskyy; A Bychko; V Sokolova; S Prylutska; M Evstigneev; V Rybalchenko; M Epple; P Scharff
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2015-10-19       Impact factor: 7.328

8.  Structural determinants of water permeability through the lipid membrane.

Authors:  John C Mathai; Stephanie Tristram-Nagle; John F Nagle; Mark L Zeidel
Journal:  J Gen Physiol       Date:  2008-01       Impact factor: 4.086

9.  Coencapsulation of alendronate and doxorubicin in pegylated liposomes: a novel formulation for chemoimmunotherapy of cancer.

Authors:  Hilary Shmeeda; Yasmine Amitay; Jenny Gorin; Dina Tzemach; Lidia Mak; Stephan T Stern; Yechezkel Barenholz; Alberto Gabizon
Journal:  J Drug Target       Date:  2016-06-06       Impact factor: 5.121

10.  Effect of doxorubicin on the order of the acyl chains of anionic and zwitterionic phospholipids in liquid-crystalline mixed model membranes: absence of drug-induced segregation of lipids into extended domains.

Authors:  F A de Wolf; K Nicolay; B de Kruijff
Journal:  Biochemistry       Date:  1992-09-29       Impact factor: 3.162
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.